- Latest news▼
-
23:55, April 29 Ketodiet improved the condition of patients with schizophrenia and bipolar disorder
-
19:47, April 29 In 64% of COVID-19 survivors, the condition worsens after one year
-
15:41, April 29 ECU: body tilt in patients after stroke was found to be curable
-
13:37, April 29 Blood: blood cancer drugs may be useful in rheumatoid arthritis
-
13:15, April 29 362 cases of measles recorded in Armenia so far in 2024
-
11:48, April 29 3 women diagnosed with HIV for first time after getting ‘beauty injections’ in US
-
15:32, April 26 ESCMID: New method of purifying the air with ultraviolet light could protect world from new pandemic
-
08:43, April 26 Enzymes that convert different blood groups into first group are discovered
-
19:41, April 25 Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference
-
17:31, April 25 JAMA: patient grew long, curly eyelashes because of chemotherapy
-
11:08, April 25 Mpox epidemic declared in Republic of the Congo
-
08:31, April 25 OU: quitting smoking 4 times more likely to cure laryngeal cancer
-
01:20, April 25 Paralyzed man in China writes hieroglyphs using neural implants placed in his brain
-
15:11, April 24 Zombie deer disease possibly linked to hunters’ deaths
-
12:27, April 23 Appetite: Scientists found out the secret to the appeal of large portions of fast food
All materials
Staphylococcus aureus may help SARS-CoV-2 multiply
Staphylococcus aureus in the laboratory helps SARS-CoV-2 virus multiply, scientists from the University of Western Ontario have found, iScience reported.
Staphylococcus aureus is often the cause of secondary bacterial infection in various acute respiratory infections. Previously, studies have shown that bacteria and viruses can interact at the molecular level, contributing to each other's reproduction.
In the new study, scientists analyzed the relationship between methicillin-resistant Staphylococcus aureus (MRSA) and SARS-CoV-2 (strain USA300 LAC) and found that the bacterium increased the rate at which the virus multiplied in epithelial cells by 10 times. At the same time, the virus had no significant effect on bacterial growth.
The genetic variant of Staphylococcus isdA provided a proviral effect for the bacteria. Drugs acting on products of this gene could disrupt the interaction between bacterial proteins and respiratory viruses. The results of the study are to be tested on living organisms.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference
- First Armenian-German Conference entitled “Heart Failure Spring School”
- Allogeneic bone marrow transplant in case of hematological malignancy performed in Armenia for first time
All materials
- Archive
- Most read
month
week
day
- Zombie deer disease possibly linked to hunters’ deaths 1417
- Paralyzed man in China writes hieroglyphs using neural implants placed in his brain 1274
- Mpox epidemic declared in Republic of the Congo 1246
- Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference 1135
- JAMA: patient grew long, curly eyelashes because of chemotherapy 1133
- OU: quitting smoking 4 times more likely to cure laryngeal cancer 1083
- Enzymes that convert different blood groups into first group are discovered 1030
- ESCMID: New method of purifying the air with ultraviolet light could protect world from new pandemic 1004
- 3 women diagnosed with HIV for first time after getting ‘beauty injections’ in US 622
- 362 cases of measles recorded in Armenia so far in 2024 431
- Blood: blood cancer drugs may be useful in rheumatoid arthritis 347
- ECU: body tilt in patients after stroke was found to be curable 346
- In 64% of COVID-19 survivors, the condition worsens after one year 331
- Ketodiet improved the condition of patients with schizophrenia and bipolar disorder 318
- Find us on Facebook
- Poll